Unknown PHASE2 INTERVENTIONAL 2-arm NCT04526353

Early Oxybutinin Treatment for Boys With Posterior Urethral Valves (PRETIPUV)

Prospective Randomized Clinical Trial of Early Oxybutinin Treatment for Boys With Posterior Urethral Valves

Sponsor: University Hospital, Bordeaux

Updated 5 times since 2020 Last updated: Aug 24, 2020 Started: Sep 10, 2020 Primary completion: Sep 10, 2023 Completion: Sep 10, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Male Urogenital Diseases, this trial is ongoing. The trial is conducted by University Hospital, Bordeaux and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2023 [monthly]

Not Yet Recruiting PHASE2
Sep 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Bordeaux

Data source: University Hospital, Bordeaux

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.